Innovative

Medicines for

Betterment of Life

Timeline Growth & Milestones

Timeline Growth & Milestones

1994

Bosch Pharmaceuticals was founded, which served as the first plant in Pakistan with three dedicated sterile areas and pioneer producers of cephalosporin injectables nationally

1997

Increased manufacturing facilities from 50,000 sq ft to 150,000 sq ft to meet the growing requirement of the market

1998

Installed in-house glass ampoule manufacturing under technical collaboration of Schott glass Germany

2000

Acquired place amongst the top 50 pharmaceutical manufacturers in the country and acquired ISO 9001 certification from SGS Belgium

2003

Launched new marketing divisions to accommodate the upcoming range of products

2005

Commenced production in the first dedicated Penicillin manufacturing plant of Pakistan

2007

Started production in the first lyophilization facility of Pakistan, manufacturing PPI Infusion and Vancomycin CP in Pakistan

2009

Launched complete range of Co-Amoxiclav in Pakistan with the introduction of Calamox - Duo. Also launched internationally available, Paracetamol infusion under the brand name of Bofalgan

2010

Launched Carbapenem group of products Cilapen (Imipenem + Cilastatin) and Penro (Meropenem) by manufacturing first time in Pakistan

2011

Started production in Bosch Plant II, our state- of -the -art large volume parenteral and liquid infusion filling plant with current capacity of 120,000 infusions and 250,000 ampoules per day

2014

Established new Good Warehouse Practices compliant dedicated warehousing facilities to meet the growing requirements. Also acquired world’s first Halal certification for pharmaceutical industry

2016

Started construction on Pakistan’s largest dedicated cGMP compliant penicillin plant covering 300,000 sq.ft

2020

Setting up Pakistan’s largest dedicated Penicillin API plant at Port Qasim, Karachi

2022

Started production of Pakistan’s largest cGMP compliant penicillin plant with state-of-art facilities of injectable powder vials, dry suspensions, capsules and tablets to cover Pakistan and world market. Became 7th largest pharmaceuticals in Pakistan